Today, Lorne Steinberg commented about whether ING-N, CVS-N, ALL-N, TD-T, GE-N, DIS-N, FFH-T, BTI-N, PYPL-Q, WMT-N, CNQ-T, XHY-T, CTC.A-T, BRK.B-N, MS-N, AMZN-Q, UBS-N, ATD-T, T-T, RY-T, GSK-N, GS-N, TRP-T, BCE-T, IFC-T, LB-T, RNW-T, ENB-T are stocks to buy or sell.
In general, the high-yield bond market is yielding at least 300-400 bps above investment-grade bonds. This one should have that yield advantage, and if it doesn't, there's an issue. Yield is 5.8%, and the high-yield bond market is yielding over 8%. He's going to take a look at this ETF after the show.
The most retail-focused of the Canadian banks, and they do it very well. Very steady business, great credit controls. Solid dividend, good growth. Core holding.
Fears of recession are real, but won't be hurt too badly in mortgage market. Not expecting a big increase in non-performing loans. Loan books are in great shape, as regulations result in bigger risks shifting to non-bank lenders.
Increase in catastrophic losses means most insurers are suffering this year. For P&C insurers, bad news is good news, as they just raise prices. Great capital allocators. Raise dividends. Favour profits over market share, so divesting unprofitable businesses. Spectacularly well run. Free cashflow machine. Yield is 3.28%.
(Analysts’ price target is $125.32)Best-run, widest healthcare business in the US. In so many areas. Free cashflow generator. Debt is manageable, and it's being reduced. 8x earnings. Foot traffic and consumer spending are down. Competitive pressures, but he expects them to gain more business than they're losing (as from Blue Shield). Yield is 3.68%.
(Analysts’ price target is $92.26)
Largest wealth manager in the US, having scaled back from investment banking and trading. Lots of free cashflow, in great financial shape, steady dividend increases, hefty dividend. Core holding. More stable and conservative than JPM, which he also owns. Yield is 4%.